Global /South Korea /Healthcare /Biotechnology /348150

KoBioLabs, Inc.

348150

• KRX: 348150 • Delayed

5,490KRW 2.4%

3.60 USD

As of 10 June 2026, KoBioLabs, Inc. has a market cap of $69.81M USD, ranking #28104 globally and #1469 in South Korea. It ranks #2537 in the Healthcare sector, and #489 in the Biotechnology industry.

Global Rank

28104

Country Rank

1469

Sector Rank

2537

Industry Rank

489

Key Stats

Market Cap

$69.81MUSD

106.61B KRW

Enterprise Value

$59.09MUSD

90.24B KRW

Revenue (TTM)

$45.38MUSD

69.29B KRW

EBITDA (TTM)

-$4.5MUSD

-6.87B KRW

Net Income (TTM)

-$4.15MUSD

-6.33B KRW

EBITDA Margin

-9.9%

Profit Margin

-9.1%

PS Ratio

1.5

PB Ratio

2.2

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

CEO

Han Seung Lee open_in_new

Founded

2014

Website

kobiolabs.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.4%	1.5%	-17%	-9.2%	3.3%	-6.5%	3.1%	-59%	-85%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	348150 고바이오랩 Ordinary Shares ISIN: KR7348150004 Shares Out.: Shares Outstanding: 19.419M¹ Shares Float: 13.55M² TV: TradingView: KRX: 348150 SA: Stock Analysis: KRX: 348150 YF: Yahoo Finance: 348150.KS GF: Google Finance: KRX: 348150 BA: Barron's: 348150 MS: Morningstar: XKRX: 348150	5,490 KRW	TV: TradingView: KRX: 348150 SA: Stock Analysis: KRX: 348150 YF: Yahoo Finance: 348150.KS GF: Google Finance: KRX: 348150 BA: Barron's: 348150 MS: Morningstar: XKRX: 348150

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About KoBioLabs, Inc.

KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and brain diseases. The company was founded in 2014 and is based in Seoul, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$44.65B 68.19T KRW 64K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$28.0B 42.76T KRW 40K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.32B 20.33T KRW 19K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.48B 8.37T KRW 8K%	-	South Korea
Peptron, Inc. KRX: 087010	$3.98B 6.07T KRW 6K%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.24B 3.42T KRW 3K%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 261K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 229K%	19.0	United States
argenx SE EBR: ARGX	$47.72B 41.39B EUR 68K%	39.9	Netherlands
CSL Ltd. ASX: CSL	$42.46B 60.27B AUD 61K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.26B 33.71B CHF 60K%	37.2	Switzerland
Natera, Inc. NASDAQ: NTRA	$27.6B 39K%	-	United States

chevron_leftBack